MHC-related protein 1–restricted recognition of cancer via a semi-invariant TCR-α chain
Authors:
- Garry DoltonGDGarry Dolton
- Hannah ThomasHTHannah Thomas
- Li Rong TanLTLi Rong Tan
- Stephanie DoetschSDStephanie Doetsch
- Giulia-Andreea IonescuGIGiulia-Andreea Ionescu
- Lucia F. CardoLCLucia F. Cardo
- Michael D. CrowtherMCMichael D. Crowther
- Théo MorinTMThéo Morin
- Marine E. CaillaudMCMarine E. Caillaud
- Devinder SraiDSDevinder Srai
Open Access
- 2 January 2025
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 135 (1)
Abstract
The T cell antigen presentation platform MR1 consists of 6 allomorphs in humans that differ by no more than 5 amino acids. The principal function of this highly conserved molecule involves presenting microbial metabolites to the abundant mucosal-associated invariant T (MAIT) cell subset. Recent developments suggest that the role of MR1 extends to presenting antigens from cancer cells, a function dependent on the K43 residue in the MR1 antigen binding cleft. Here, we successfully cultured cancer-activated, MR1-restricted T cells from multiple donors and confirmed that they recognized a wide range of cancer types expressing the most common MR1*01 and/or MR1*02 allomorphs (over 95% of the population), while remaining inert to healthy cells including healthy B cells and monocytes. Curiously, in all but one donor these T cells were found to incorporate a conserved TCR-α chain motif, CAXYGGSQGNLIF (where X represents 3–5 amino acids), because of pairing between 10 different TRAV genes and the TRAJ42 gene segment. This semi-invariance in the TCR-α chain is reminiscent of MAIT cells and suggests recognition of a conserved antigen bound to K43.Keywords
Funding Information
- Wellcome Trust (220295/Z/20/Z)
- Cancer Research UK (CGCATF-2021/100001)
- Mark Foundation For Cancer Research (CGCATF-2021/100001)
- Cancer Research Wales (Tom Walker PhD Studentship for Acute Myeloid Leukaemia Research)
- Tenovus (PhD2019-28)
- Instituto Nacional de Cancerología (CA278656-01)
This publication has 50 references indexed in Scilit:
- Different T Cell Receptor Affinity Thresholds and CD8 Coreceptor Dependence Govern Cytotoxic T Lymphocyte Activation and Tetramer Binding PropertiesJournal of Biological Chemistry, 2007
- CD8 exerts differential effects on the deployment of cytotoxic T lymphocyte effector functionsEuropean Journal of Immunology, 2007
- Interaction between the CD8 Coreceptor and Major Histocompatibility Complex Class I Stabilizes T Cell Receptor-Antigen Complexes at the Cell SurfaceJournal of Biological Chemistry, 2005
- Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1Nature, 2003
- Quantitative Analysis of the Contribution of TCR/pepMHC Affinity and CD8 to T Cell ActivationImmunity, 2003
- The Human CD8 Coreceptor Effects Cytotoxic T Cell Activation and Antigen Sensitivity Primarily by Mediating Complete Phosphorylation of the T Cell Receptor ζ ChainJournal of Biological Chemistry, 2001
- Crystal structure of the complex between human CD8αα and HLA-A2Nature, 1997
- Expression of Two T Cell Receptor α Chains: Dual Receptor T CellsScience, 1993
- Differential expression and regulation of the human CD8α and CD8β chainsTissue Antigens, 1990
- The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine-protein kinase p56lckCell, 1988